Testing of Medication Dosing Software
Testing of a Medication Dosing Software for Pediatric Emergency Care
1 other identifier
interventional
12
0 countries
N/A
Brief Summary
The goal of this clinical study is to evaluate the clinical efficiency of a medication dosing software in simulated pediatric emergency care. The main questions it aims to answer are:
- Will the time to patient be significantly reduced with the medication dosage software when compared to standard clinical practice?
- Will the time to calculate dosage of medications be significantly reduced with the medication dosage software when compared to standard clinical practice?
- How will users perceive clinical efficiency, ease of use, confidence level of using the medication dosage software when compared to standard clinical practice?
- How will accuracy of medication dose and volume calculations as well as final volume ready for administration using the medication dosage software compared to standard clinical practice?
- Will the time spent calculating medication doses by the second healthcare professional on pediatric non-acute and acute care cases be significantly reduced with the medication dosage software when compared to standard clinical practice? Participants will be presented pediatric care scenarios and asked to calculate and prepare intravenous medications under two interventions: the medication dosage software and standard clinical practice (Lexicomp and manual calculator).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2023
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 3, 2023
CompletedFirst Posted
Study publicly available on registry
November 13, 2023
CompletedStudy Start
First participant enrolled
December 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2024
CompletedNovember 13, 2023
November 1, 2023
3 months
November 3, 2023
November 8, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
TIme to patient
Assess the time elapsed from ordering of medication to ready for administration using the medication dosage software compared to the time achieved with standard clinical practice
Through study completion, up to 3 months
Time to calculate
Assess the time to calculate medication dosage using the medication dosage software compared to standard clinical practice
Through study completion, up to 3 months
Secondary Outcomes (3)
Feedback
Through study completion, up to 3 months
Accuracy
Through study completion, up to 3 months
Time of calculation by second healthcare professional
Through study completion, up to 3 months
Study Arms (2)
Software, then Standard
EXPERIMENTALParticipants will use the medication dosage software to calculate and prepare intravenous medications during the initial run through of pediatric case scenarios. Then, they will use standard clinical practice (Lexicomp and manual calculator) during the second run through of pediatric case scenarios.
Standard, then Software
EXPERIMENTALParticipants will use standard clinical practice (Lexicomp and manual calculator) to calculate and prepare intravenous medications during the initial run through of pediatric case scenarios. Then, they will use the medication dosage software during the second run through of pediatric case scenarios.
Interventions
Medication dosing software
Eligibility Criteria
You may qualify if:
- Healthcare professionals who have worked or who are currently working at a healthcare facility and involved in the calculation or preparation of IV medication.
You may not qualify if:
- Healthcare professionals who cannot read, speak, or understand English or French as the simulations will be conducted in English or French.
- Performance of physically strenuous activity 30 min prior to study.
- Physical limitations that affect performance on required tasks (e.g., inability to place arm cuff on mannequin's arm, inability to handle weight estimation and touchscreen devices).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nura Medicallead
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 3, 2023
First Posted
November 13, 2023
Study Start
December 1, 2023
Primary Completion
March 1, 2024
Study Completion
April 1, 2024
Last Updated
November 13, 2023
Record last verified: 2023-11